Class Assignment — Week 1 1) Biological Engineering Application I aim to develop a computational and experimental platform for engineering metabolically constrained microbial systems designed for responsible real-world use. Inspired by clinical exposure to preventable infectious disease and my research at the intersection of microbiology and computational biology, the platform integrates genomic design rules, programmed auxotrophies, and environmental sensing circuits that couple microbial survival to defined ecological contexts.
Class Assignment — Week 2 Part 1 — Sequence Retrieval and Design Workflow 1) Sequence Retrieval and Benchling Initialization The process began with obtaining a Lambda GenBank file from New England Biolabs. After confirming the correct format, I imported the file into Benchling as a DNA sequence. Care was taken to ensure that the file was not mistakenly uploaded as RNA and that annotations displayed properly within the platform.
Class Assignment — Week 3 1) Opentrons Artwork 2) Published Papers Utilizing Automation LabscriptAI — Autonomous Liquid-Handling Robotics Scripting Gao et al., 2025 introduce LabscriptAI, a multi-agent framework that translates natural language experimental descriptions into validated Python scripts for heterogeneous liquid-handling robots, including Opentrons platforms.
Fitness-aware design of engineered probiotics under ecological and evolutionary constraints.
This project is a model-first, constraint-aware approach to engineering E. coli Nissle 1917 (EcN) as a gut sentinel: sensing context, responding with targeted antimicrobials, and remaining governable through built-in containment.
Inspiration
Where this came from
During my medical training in Osogbo, diarrheal admissions became a rhythm I could not ignore. Children arrived dehydrated, eyes sunken, mothers anxious yet composed in that uniquely Nigerian way, strong because they had to be. We gave ORS, zinc, fluids. Sometimes antibiotics “just in case.” Sometimes it worked. Sometimes the silence afterward stayed with me longer than the ward round.
In microbiology, I encountered E. coli again, this time not only as culprit but as chassis. That shift lingered. What if the organism we blamed could be redesigned as a responder—quiet in health and active only when toxin or inflammatory signals rise—constrained and context bound, unable to persist beyond intention?
The idea was not dramatic. It was patterned. Repetition in the pediatric ward met ecological thinking in the lab. If microbes shape disease landscapes, perhaps they can also stabilize them—precisely, intelligently, and safely—within the same environments where I first learned to treat the consequences.
Why this matters
Childhood diarrhoeal disease remains high-burden with persistent treatment gaps, despite well-known interventions. The ambition here is not spectacle—it is reliable behavior under pressure: a responder that stays quiet in health, activates only under risk signals, and remains bounded by design.
Core design stance
Optimize for stability, not just performance. I’m not chasing one “best construct.” I’m mapping design regimes: what works, what breaks, and what stays governable as conditions shift—fitness cost vs efficacy, signal vs noise, activation vs survivability.
System overview
ÌṢỌ is designed as a three-layer system:
Detection: a biosensor tuned to a pathogen-associated signal or inflammation-linked marker
Response: context-dependent expression of targeted antimicrobials (microcins)
Containment: survival becomes conditional via metabolic dependency (“metabolic contract”)
Modeling assumptions & constraints
Burden matters: expression cost is a first-class design variable, not a footnote
Selection is always running: anything that reduces fitness will be negotiated by evolution
The gut isn’t a flask: competition and variability are the setting, not edge-cases
Outputs are design guidance: models inform what to build next, not clinical claims
Containment is a system property: not only “does it exist,” but “does it hold under pressure?”
Out of scope (Spring 2026)
Wet-lab validation
Full microbiome ecosystem simulation
Inventing novel antimicrobials
Clinical deployment trials
Regulatory implementation
Pipeline
Model → explore → optimize → stress-test.
The goal is to produce:
reproducible computational models
tradeoff plots (fitness vs efficacy)
robustness/sensitivity analyses
design regimes rather than a single “optimal” construct
Circuit modules
Module 1 — Biosensor: reads a context signal and gates activation to reduce unnecessary burden
Module 2 — Regulator: thresholded activation to limit leaky expression and improve stability under selection
Module 3 — Effector (microcin): narrow-spectrum antimicrobial peptides aiming to pressure pathogens while minimizing broader disruption
Module 4 — Containment: metabolic dependency to embed governance in biology
Governance & biosafety
Metabolic Dependency: if the engineered organism is made dependent on an externally supplied essential metabolite, it becomes non-viable without deliberate human-provided support.
Ecological Firewall: escapees cannot persist in nature, reducing ecological risk.
Human-Controlled Survival (“metabolic contract”): survival is coupled to oversight and supply chains, embedding accountability into the organism’s survival logic.
References
Ba, F., Zhang, Y., Ji, X., Liu, W.-Q., Ling, S., & Li, J. (2023). Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology. bioRxiv. https://doi.org/10.1101/2023.06.05.543671
Egbewale, B. E., Karlsson, O., & Sudfeld, C. R. (2022). Childhood Diarrhea Prevalence and Uptake of Oral Rehydration Solution and Zinc Treatment in Nigeria. Children, 9(11), 1722. https://doi.org/10.3390/children9111722
Gayawan, E., Cameron, E., Okitika, T., Egbon, O. A., & Gething, P. (2024). A situational assessment of treatments received for childhood diarrhea in the Federal Republic of Nigeria. PLOS ONE, 19(5), e0303963. https://doi.org/10.1371/journal.pone.0303963
Lynch, J. P., Goers, L., & Lesser, C. F. (2022). Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics. Trends in Pharmacological Sciences, 43(9). https://doi.org/10.1016/j.tips.2022.02.002
Palmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V. (2017). Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47. ACS Infectious Diseases, 4(1), 39–45. https://doi.org/10.1021/acsinfecdis.7b00114
Weibel, N., Curcio, M., Schreiber, A., et al. (2024). Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases. ACS Synthetic Biology, 13(8), 2376–2390. https://doi.org/10.1021/acssynbio.4c00036
I aim to develop a computational and experimental platform for engineering metabolically constrained microbial systems designed for responsible real-world use. Inspired by clinical exposure to preventable infectious disease and my research at the intersection of microbiology and computational biology, the platform integrates genomic design rules, programmed auxotrophies, and environmental sensing circuits that couple microbial survival to defined ecological contexts.
The central principle is ecological boundedness. Survival and function are conditional, not assumed. Outside intended environments, persistence becomes biologically untenable. This approach supports applications ranging from gut-targeted probiotics to agricultural symbionts and environmental remediation strains.
Rather than optimizing microbes solely for performance, I want to encode responsibility at the level of metabolism. The goal is to expand synthetic biology into high-need contexts while ensuring that safety, containment, and contextual awareness are intrinsic design features, not external corrections imposed after deployment.
2) Governance and Policy Goals
My overarching governance goal is to embed non-malfeasance directly into biological architecture rather than relying exclusively on downstream regulation.
First, intrinsic containment standards should become normative. This includes requiring conditional survival mechanisms such as auxotrophies or environmental dependency circuits prior to field deployment, alongside independent validation of escape potential and evolutionary stability.
Second, dual-use mitigation must be integrated into design pipelines. Sequence screening, risk-tiered access controls, and transparent but bounded documentation standards can reduce misuse without stifling legitimate research.
Third, equity should shape access and deployment. Safety-audited open frameworks should remain available to researchers in low-resource settings, and deployment priorities should align with public health and ecological need rather than purely commercial incentives.
Together, these goals move governance upstream. Ethical alignment becomes encoded in design logic, enabling innovation that is both socially responsive and technically responsible.
3) Governance Actions
Option 1 — Conditional Deployment Requirement
Purpose: Shift from voluntary containment to mandatory intrinsic safeguards for field-deployable microbes. Design: Regulators require documented metabolic constraints and third-party validation before approval. Academic labs and companies must comply. Assumptions: Safeguards remain evolutionarily stable and measurable. Risks: Overregulation may slow beneficial innovation; success may create complacency about residual risk.
Purpose: Embed sequence screening and risk assessment into computational design tools. Design: Tool developers, funders, and journals require automated biosecurity checks as part of research workflows. Assumptions: Screening algorithms remain adaptive to emerging threats. Risks: False positives could burden researchers; sophisticated actors might bypass systems.
Option 3 — Incentivized Safety Certification
Purpose: Encourage responsible innovation through market and funding incentives. Design: Grant agencies and industry consortia prioritize projects meeting certified intrinsic-containment standards. Assumptions: Financial incentives shape behavior effectively. Risks: Certification may become symbolic rather than substantive if poorly enforced.
4) Scoring Governance Actions
Criteria
Option 1
Option 2
Option 3
Enhance Biosecurity (prevent incidents)
1
1
2
Enhance Biosecurity (respond)
2
2
2
Foster Lab Safety (prevent)
1
2
2
Protect Environment (prevent)
1
2
2
Minimize Burden
3
2
1
Feasibility
2
1
1
Not Impede Research
3
1
1
Promote Constructive Applications
1
1
1
1 indicates strongest alignment.
5) Prioritization and Trade-offs
I would prioritize a combination of Option 2 and Option 3. Embedding screening directly into computational design tools makes safety habitual rather than exceptional, while incentive structures reinforce responsible norms without heavy-handed regulation.
Option 1 is powerful but risks slowing innovation in resource-constrained contexts where deployment urgency is high. My recommendation would target national research funders and international synthetic biology consortia, encouraging coordinated standards that scale globally.
Trade-offs include balancing speed with precaution and avoiding regulatory inequities that disadvantage researchers in low-income settings. Uncertainties remain regarding evolutionary stability of safeguards and adaptability of screening systems.
The central ethical concern that emerged for me is the illusion of control. Engineering containment does not eliminate uncertainty. Governance must remain adaptive, transparent, and humble, recognizing that biological systems are dynamic. Embedding responsibility into design is necessary, but continuous oversight and global dialogue remain essential.
Class Assignment — Week 2 Preparation
1) Essential Amino Acids and the Lysine Contingency
The ten essential amino acids in animals are histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, and arginine (essential in growing animals). Animals cannot synthesize these; survival depends on dietary supply.
This reframes the Lysine Contingency for me. It is not merely a clever containment device. Engineering microbes that require lysine creates a metabolic dependency aligned with a biological universal. Because animals cannot produce lysine, ecological persistence becomes tightly coupled to controlled supplementation. Survival becomes conditional, not autonomous.
I now see it less as a biosafety patch and more as a governance-embedded metabolic contract. The dependency encodes authority into biochemistry. Control is not enforced externally; it is written into the organism’s survival logic. That shift moves containment from policy language into molecular architecture.
2) Suggested Code for AA:AA Interactions
From the genetic code logic shown, base pairs have symmetry rules. Amino acids need something analogous. I would propose a layered interaction code:
First layer: chemical class (polar, nonpolar, charged, aromatic). Second layer: interaction type (hydrophobic packing, hydrogen bonding, ionic pairing, pi stacking). Third layer: geometry constraint (distance and orientation tolerance).
For example, NP-HYD-G1 could denote nonpolar hydrophobic packing within a defined geometric band. CH-ION-G2 could represent oppositely charged ionic interaction with specific spacing tolerance.
Such a code treats protein structure not as artistic folding but as readable and writable interaction grammar. If we can read polymers, we should also encode their interaction rules explicitly. That shift makes protein design less descriptive and more programmable.
3) Ethical Reflections
Biological systems do not respect borders. Political, institutional, even disciplinary lines dissolve in ecology. Framing safety as compliance feels incomplete because evolution does not comply. Good intentions are structurally irrelevant to selection pressures.
Governance must therefore treat evolution as a first-class design constraint. Safeguards must assume mutation, drift, and ecological leakage. Ethical assumptions should be embedded in design architectures, not appended through oversight committees.
I am increasingly drawn to resilience-based governance. Instead of trusting actors, we engineer systems that remain bounded even under failure. The goal is not perfect control but constrained adaptability. In living systems, humility is ethical. Governance must anticipate dynamics, not merely regulate behavior.
Key Takeaways
Evolution is not theoretical. Population genetics, mutation rates, and selection coefficients are active in every gut. Any safeguard must assume adaptation under pressure.
Biology is programmable matter. DNA is a chemically precise information system. If we can write sequence, responsibility must be encoded at that same molecular layer.
Genetic recoding reshapes constraints. Codon reassignment and translational control can structurally limit horizontal gene transfer.
Design capacity is accelerating. Sequencing and synthesis technologies now scale faster than the institutions meant to guide them.
Design obeys physics. Protein folding, metabolic flux, and regulatory circuits follow thermodynamics and kinetics. Only systems stable under stress earn trust.
AI Prompts Employed
Help me design a scientific but warm homepage visual, iterate fast, and fix what breaks
Help me turn this from a messy course site into a coherent research story
Help me debug under deadline without losing momentum
Help me sound credible, grounded, and original — not speculative or sloppy
Make contact details easy to find me without making it cringe
Week 2
Class Assignment — Week 2
Part 1 — Sequence Retrieval and Design Workflow
1) Sequence Retrieval and Benchling Initialization
The process began with obtaining a Lambda GenBank file from New England Biolabs. After confirming the correct format, I imported the file into Benchling as a DNA sequence. Care was taken to ensure that the file was not mistakenly uploaded as RNA and that annotations displayed properly within the platform.
This step established a stable working environment before any design modifications were introduced. Confirming correct topology and annotation structure prevented downstream formatting or visualization issues.
2) Genomic Exploration and Annotation Familiarization
Once imported, I explored the annotated regions of the Lambda genome within Benchling. This involved confirming gene orientation, identifying labeled regions, and understanding the graphical interface for both linear and circular visualization.
Although exploratory, this step reinforced familiarity with the design environment. It ensured that I could distinguish between expected gene clusters and annotation artifacts, and that I could confidently navigate the interface for subsequent editing.
3) Protein Selection and Sequence Acquisition
Furthermore, I selected Microcin M as the protein of interest. The choice aligned with my project, ÌṢỌ, which focuses on context-sensitive antimicrobial response within the gut ecosystem.
The selection criteria included:
Narrow-spectrum antimicrobial activity
Relevance to microbial competition
Compatibility with a governed probiotic chassis
The amino acid sequence was retrieved in FASTA format from a reliable database (NCBI GenBank: CAE55705.1). I verified the header structure and ensured that the sequence corresponded exactly to the intended protein.
4) Reverse Translation
Using Benchling’s reverse translation functionality, I converted the amino acid sequence into a nucleotide sequence suitable for expression in Escherichia coli.
Key considerations included:
Maintaining correct reading frame
Ensuring inclusion of a start codon
Confirming appropriate stop codon placement
Selecting E. coli codon usage
The output DNA sequence was checked to ensure it translated back to the original protein sequence without truncation or frame shift.
5) Codon Optimization
Following reverse translation, codon optimization was performed for expression in E. coli. This step aimed to improve translational efficiency while minimizing expression burden and avoiding rare codons.
Optimization included:
Aligning codon usage with host bias
Avoiding problematic restriction sites
Preserving protein sequence integrity
This stage reinforced that codon choice influences not only protein yield but also metabolic load and evolutionary stability.
Part 2 — Construct Assembly and Validation
6) Expression Cassette Assembly
The optimized coding sequence was integrated into a complete expression cassette using the assignment’s structural framework:
Promoter → Ribosome Binding Site → Start Codon → Codon-Optimized CDS → Optional His Tag → Stop Codon → Terminator
Each component was manually inserted and annotated within Benchling. Particular care was taken to ensure that the coding region replaced the example scaffold sequence rather than being appended to it.
Linear and circular map views were used to confirm structural continuity, annotation accuracy, and absence of unintended sequence artifacts.
7) Virtual Digest and Gel Simulation
To validate construct integrity, I performed a virtual digest within Benchling and obtained predicted fragment sizes. These fragment sizes were then visualized using an external gel simulation tool.
This step confirmed that the construct behaved as expected under restriction enzyme analysis and reinforced my understanding of plasmid verification workflows.
8) FASTA Export and Synthesis Preparation
The completed expression cassette was exported in FASTA format for potential synthesis ordering. Care was taken to ensure:
Correct header formatting beginning with the greater-than symbol
No extraneous spaces or formatting characters
Proper file extension
Although synthesis ordering through Twist was initiated, access limitations prevented full completion. Instead of halting progress, I pivoted toward generating a complete plasmid visualization within Benchling.
9) Plasmid Map Generation
To simulate a complete plasmid construct, the sequence topology was converted to circular within Benchling. Circular map visualization confirmed clear annotation of promoter, ribosome binding site, coding sequence, and terminator.
This produced a plasmid map without requiring external synthesis confirmation. The visualization ensured structural coherence and clear representation of the engineered construct.
Technical Milestones Achieved
Successful import and annotation of GenBank files
Accurate reverse translation from protein to DNA
Codon optimization aligned with host expression
Proper construction of an annotated expression cassette
Verified FASTA export formatting
Simulated plasmid visualization in circular topology
Integration of molecular workflow with ecological design philosophy
Design Integration
Throughout the experience, I maintained alignment with the core principles of ÌṢỌ:
Fitness cost is a primary design variable
Selection operates continuously
Expression burden affects evolutionary stability
Containment must be intrinsic to architecture
Models inform design boundaries
This reframed it for me from a cloning exercise into a constraint-aware engineering process.
Process Reflections
The workflow required iterative verification at each stage. Formatting, reading frame integrity, codon usage, annotation accuracy, and topology conversion each presented potential points of error and addressing them incrementally reduced compounding mistakes.
More importantly, it reinforced that biological engineering is not simply about inserting genes. It requires contextual awareness, ecological humility, and structural foresight.
Sequence design is only the beginning. Stability under pressure determines whether a system is viable outside controlled conditions.
This process strengthened both my technical fluency and design discipline, linking molecular implementation to ecological responsibility.
Gao et al., 2025 introduce LabscriptAI, a multi-agent framework that translates natural language experimental descriptions into validated Python scripts for heterogeneous liquid-handling robots, including Opentrons platforms.
The system integrates:
Hierarchical task planning
Platform-specific simulation validation
A precise refactoring engine for targeted debugging
Domain-specific knowledge retrieval
Human-in-the-loop safety checkpoints
Experimental validation included:
Cross-platform fluorescence calibration
Automated cell-free expression and screening of 298 GFP variants
The central contribution is not pipetting precision alone. It is structured experimental execution with embedded validation and safety logic. Automation becomes reproducible, cross-platform, and governable.
Active Learning Directed Evolution (ALDE)
Active Learning Directed Evolution which integrates machine learning uncertainty estimation with iterative experimental screening to guide protein engineering efficiently was introduced by Yang, Lal, Arnold, et al. 2025.
ALDE automates experimental decision-making by:
Training predictive sequence–function models
Quantifying uncertainty across unexplored sequence space
Selecting optimal next-round variants
Iteratively refining search trajectories
Rather than brute-force screening, ALDE navigates design space intelligently, minimizing experimental waste while maximizing functional discovery.
Together, these systems represent complementary layers:
ÌṢỌ is a fitness-aware engineered probiotic system designed to sense gut context, produce targeted antimicrobial responses, and remain bounded through intrinsic containment.
Automation enables a structured Design–Build–Test–Learn loop.
A) Combinatorial Genetic Circuit Screening (requires automation)
Objective: Evaluate sensor–effector variants under growth constraints.
Automated workflow:
Dispense transformation master mix into 96-well plate
Add plasmid constructs into defined coordinates
Perform serial dilution plating
Inoculate colonies into induction gradient
Measure OD600 for growth
Measure fluorescence for reporter output
Normalize fluorescence by growth to assess fitness-aware performance
Together, they form a closed-loop, governable engineering system that prioritizes stability under ecological pressure rather than maximal output under ideal conditions.
Works Cited
Yang, J., Lal, R. G., Bowden, J. C., et al. (2025). Active learning-assisted directed evolution. Nature Communications, 16, 714. https://doi.org/10.1038/s41467-025-55987-8
Gao, Y., Luo, Y., Li, W., Lan, Y., Jiang, H., Chen, Y., Yi, X., Li, B., Alinejad-Rokny, H., Wang, T., Fu, L., Yang, M., & Si, T. (2025). Autonomous liquid-handling robotics scripting for accessible and responsible protein engineering. bioRxiv. https://doi.org/10.1101/2025.09.30.679666
Proposed Final Project Ideas
Process Reflections
This week shifted my understanding of automation from technical convenience to systems architecture.
Initially, I approached the assignment by identifying a strong automation framework in LabscriptAI. However, as I explored complementary tools such as ALDE, it became clear that robotic precision alone is insufficient. Scalable biological engineering requires structured exploration, specifically uncertainty-aware active learning to navigate sequence and design space intelligently.
The key insight was recognizing that automation operates on two layers:
Cognitive layer deciding what experiment to run next
Execution layer safely and reproducibly running it
By combining both, my thinking moved beyond pipetting workflows toward a closed-loop, governable Design–Build–Test–Learn system. This reframing aligns directly with ÌṢỌ, which requires ecological realism, fitness awareness, and safety constraints.
Another important shift was recognizing the role of governance. Automation increases capability, but without structured safety checkpoints, biosecurity screening, and human oversight, it becomes fragile or irresponsible. Designing the automation architecture required explicit consideration of containment, ecological competition, and reproducibility.
This process strengthened three core skills:
Systems-level integration rather than tool-level selection
Designing for constraint rather than brute-force optimization
Framing automation as a platform rather than a procedure
Ultimately, I realized that my final project is not only an engineered probiotic. It is a structured, uncertainty-aware engineering pipeline for responsible biological deployment.
AI Prompts Employed
Compare ALDE and LabscriptAI to see if they work well together as a system
Design a closed-loop setup where AI chooses experiments and robots run them
List what I would automate for ÌṢỌ (Sentinel EcN)
Draft simple Opentrons-style pseudocode for running reactions
Integrate 3D printed tools, cloud labs, and governance into the automation workflow